BRIEF-Adamis receives response letter from FDA for its epinephrine syringe
June 06, 2016 at 06:55 AM EDT
* FDA indicated that in order to support approval of product, company must expand its human factors study
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|